2 ASX 200 shares with enough pricing power to battle inflation: Expert

An expert has tipped Transurban and Resmed shares as potential inflation safe havens.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rising inflation has been the talk of the town in 2022 and S&P/ASX 200 Index (ASX: XJO) shares aren't immune from its bite.

In fact, many ASX 200 technology shares have been hit hard by the shifting landscape. The S&P/ASX 200 Information Technology Index (ASX: XIJ), for example, has plunged nearly 38% year to date.

So, which ASX 200 shares can investors trust to grow their hard-earned money in 2022?

Head of Australian equities at T. Rowe Price, Randal Jenneke has flagged two stocks he believes have plenty of pricing power and could act as inflation hedges.

A woman sits in contemplation with superimposed images of piles of gold coins, graphs, and star-like lights above her head as though she is thinking about investment options.

Image source: Getty Images

2 ASX 200 shares to buy in times of inflation

There are two likely ways Australia's current inflationary environment could shift, according to Jenneke.

The first – and most unlikely direction – is towards 1970s-style "stagflation". The more likely happening? Inflation continuing to rise through 2022. 

"The challenge of rising costs, whether labour or other inputs, will likely persist and contribute to higher headline inflation over the rest of the year," Jenneke said.

"[W]e will likely see investor focus shift more from top line revenue growth to margin sustainability and their volatility. We have already seen the valuation gap between high margin and high growth narrow."

And companies with strong pricing power are the most prepared to manage through such a period.

"To pass on costs effectively to buyers requires a good industry structure, differentiated products, and defensive volumes," Jenneke said.

Resmed CDI (ASX: RMD)

Fortunately, ASX 200 healthcare share Resmed has just that. Jenneke said:

Resmed … has a large under-penetrated market, and despite various input and logistics cost pressures, has been able to pass through price increases given their dominant market share and current lack of reputable competition.

The Resmed share price is currently $30.91, 14.5% lower than it was at the start of 2022.

Transurban Group (ASX: TCL)

ASX 200 infrastructure share Transurban is also set up to battle inflation, according to Jenneke, who said:

Transurban … has built-in price increases for its contracts.

The nature of its cost structure brings high [earnings before interest and tax (EBIT)] margins and margin stability. Anecdotally, you know the cost of tolls are rising when every second taxi driver makes a point or two about it.

The Transurban share price is $14.45 right now, having gained 3.6% year to date.

Finally, the expert noted, "while these are two [shares] we like, we should stress our views are supported by our fundamental insights, rather than the broader economic climate."

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A young man looks like he his thinking holding his hand to his chin and gazing off to the side amid a backdrop of hand drawn lightbulbs that are lit up on a chalkboard.
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

Close up portrait of happy businesswoman standing in front or leading her multi-ethnic corporate team.
Broker Notes

Morgans recommends these ASX shares as buys

Broker buy calls are not guarantees, but these three Morgans recommendations are worth a closer look.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

3 ASX stocks UBS rates as a buy right now

Check out which shares the experts have their eye on.

Read more »

A smiling farmer does the thumbs up amid a field of blooming sunflowers.
Broker Notes

6 ASX shares upgraded by analysts this week

Brokers see new potential in Liontown, Evolution, and other shares this week.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Broker Notes

Bell Potter says this ASX share could rise 150%+

Here's one for investors with a high tolerance for risk.

Read more »

A father helps his son look through binoculars during a family holiday or day out in the city.
Broker Notes

What is Bell Potter's updated view on Seek and REA shares?

One is a buy while the other is a sell.

Read more »

A nervous ASX shares investor holding her hands to her face in fear.
Broker Notes

Warning! 5 ASX stocks to fall 20% or more: Experts

According to the experts' 12-month share price targets, these stocks are set to tumble.

Read more »

A man looks down with fright as he falls towards the ground.
Broker Notes

4 ASX 200 shares downgraded by brokers this week

Brokers lowered their ratings on Rio Tinto, Resmed, Transurban, and others this week. 

Read more »